超華科技(002288.SZ)一季度預盈2500萬至3000萬元 同比扭虧為盈
格隆匯 2 月 26日丨超華科技(002288.SZ)公佈,預計2021年第一季度歸屬於上市公司股東的淨利潤2500萬元至3000萬元,上年同期虧損2999萬元。
受益於5G、新能源汽車、IDC、汽車電子、消費電子等領域快速發展,下遊銅箔、覆銅板需求旺盛,銅箔加工費上漲等因素帶動產品毛利率提升;同時,公司年產8,000噸高精度電子銅箔項目(二期)於2020年11月順利投產,公司銅箔產能得到較大幅度提升,公司2021年第一季度相較上年同期扭虧為盈,預計2021年第一季度實現歸屬於上市公司股東的淨利潤2500-3000萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.